Ever Source Wealth Advisors, LLC Sarepta Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 14 shares of SRPT stock, worth $326. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 133
89.47%
Holding current value
$326
Previous $8,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SRPT
# of Institutions
455Shares Held
82.4MCall Options Held
5.6MPut Options Held
4.19M-
Black Rock Inc. New York, NY10.3MShares$241 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$214 Million0.0% of portfolio
-
State Street Corp Boston, MA4.7MShares$110 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$105 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA2.53MShares$59.1 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $2.04B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...